The Blue Jays are acquiring right-hander Jose Soriano from the Angels, reports ESPN’s Jeff...
Though there’s been plenty of talk surrounding both relievers, the Padres aren’t likely to...
Zach Cregger is making waves as an acclaimed horror director now, but he once starred in a...
Get ready to remember the fun of late 1960s television all over again, for free!Starting A...
The French president could be replaced by Ukraine skeptics next year, potentially throwing...
Countries
Opinion
Bus-fare evasion is just the start of Kathy Hochul’s looming MTA cash woes
There’s no excuse for animal abuse — and LA has the power to stop it
Malibu can be saved — but it needs vision and leadership, at every level
-
NY Times News ( Middle East ) 2026/4/30David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IM...
-
Independent ( Yemen ) 2026/4/2The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
-
PR Newswire ( Middle East ) 2026/3/28Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz mon...
-
Gizmodo ( Middle East ) 2026/1/9People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
-
Quartz ( Middle East ) 2025/10/6European Association for the Study of Obesity says the drugs are so effective, they should be used for almost all obesity patients
-
Los Angeles Daily News ( Middle East ) 2025/5/12By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...
-
Quartz ( Middle East ) 2025/5/12Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...
-
News10NBC ( Middle East ) 2025/5/12People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...
- Quartz ( Middle East ) 2025/4/1
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and...
- Ukiah Daily Journal ( Middle East ) 2025/3/5
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Related ArticlesHealth |...
